Open Nav

Revivicor Inc.

  • David Ayares, Revivicor Inc.

Revivicor has established a unique line of pigs, GalSafe®, that does not have galactose alpha 1,3 galactose (α-gal) on cells, tissues, or organs. A newly discovered allergy linked to the α-gal epitope, that is present on most mammals including cows and pigs, has been recently declared an epidemic by allergists. The allergy is often referred to as α-gal syndrome or the red meat allergy. At the federal level, the Center for Disease Control (CDC) has recently initiated surveillance activity. The USDA as well as recent scientific publications report that over 25% of selected populations are pre-sensitized to α-gal via a tick bite. Exposure to α-gal from food (meat, gelatin), cosmetics (collagen) and therapeutics (heart valves, pancreatic enzymes, heparin, vaccines) has resulted in adverse events including anaphylaxis. Derivatives from GalSafe® pigs are poised to provide safer and more efficacious products than comparable products derived from conventional source animals.

  • Date:Wednesday, July 10
  • Time:1:45 PM - 2:00 PM
  • Location:318
  • Session Type:Company and Technical Presentation
  • BIO Track:Sustainability and the Future of Food
David Ayares
Revivicor Inc.